The FDA’s draft guidance on CBD enforcement policy was submitted for review by the White House Office of Management and Budget (OMB) and the OMB has now scheduled meetings with various hemp/CBD stakeholder groups
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.